• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Ardelyx, Inc. - Common Stock (NQ:ARDX)

3.230 -0.050 (-1.52%)
Delayed Quote Updated: 4:00 PM EDT, Oct 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,537,473
Open 3.280
Bid (Size) 3.200 (1,000)
Ask (Size) 3.230 (600)
Prev. Close 3.280
Today's Range 3.180 - 3.280
52wk Range 3.180 - 8.400
Shares Outstanding 103,119,010
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of November 16, 2026 in Ardelyx, Inc. Lawsuit - ARDX
Today 14:31 EDT
Ardelyx's Chief Commercial Officer, Eric Foster, is named as an individual defendant in a securities class action alleging he assured investors the Company's patient-access strategy was working while... 
From Levi & Korsinsky, LLP
Via GlobeNewswire
News headline image
Kaplan Fox Continues to Alert Investors of Ardelyx, Inc. (NASDAQ: ARDX) to a Class Action Deadline on November 16, 2026
Today 9:25 EDT
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit

Performance

52-Week Range 61.5% below 52-week high
3.230
3.1852W Low 8.4052W High
1 Week 5.2% below 1-week high
3.181W Low 3.411W High

Ardelyx, Inc. - Common Stock (ARDX) traded between $3.18 and $8.40 over the past 52 weeks and last traded at $3.23, 61.5% below its 52-week high. Over the past week it ranged between $3.18 and $3.41.

Past 12 Months
-2.4%
-8.2%
-37.2%
-49.0%
-47.5%
-35.5%
1W -$0.08
1M -$0.29
3M -$1.91
6M -$3.10
YTD -$2.92
1Y -$1.78

ARDX was -35.5% over the past year, -49.0% over six months, -47.5% year to date, -2.4% in the last week.

12 Months vs Market
ARDX
-35.5%
DIA
+12.4%
SPY
+17.4%
QQQ
+23.9%
IWM
+13.7%

Over the past 12 months ARDX returned -35.5% versus DIA (Dow) +12.4%, SPY (S&P 500) +17.4%, QQQ (Nasdaq 100) +23.9% and IWM (Russell 2000) +13.7%.

Volume & Liquidity 0.85× 3-mo avg
Today 3,537,473 3-mo avg 4.2M
1W
4.7M
1M
4.4M
3M
4.2M
6M
4.1M
YTD
4.3M
1Y
4.1M

ARDX most recently traded 3,537,473 shares against a 3-month average daily volume of 4.2M.

More News

Read More
News headline image
Ardelyx Presents Real-World Data at ACG 2026 Showing Reduced Healthcare Resource Utilization Following IBSRELA® Initiation in Adults with IBS-C
Today 8:01 EDT
From Ardelyx, Inc.
Via GlobeNewswire
News headline image
Levi & Korsinsky Reminds Ardelyx, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of November 16, 2026 - ARDX
October 09, 2026
From Levi & Korsinsky, LLP
Via ACCESS Newswire
News headline image
ARDX Investors Have Opportunity to Lead Ardelyx, Inc. Securities Fraud Lawsuit with SBS Law
October 09, 2026
From Schall, Brown & Schwartz LLP
Via GlobeNewswire
News headline image
Kaplan Fox Encourages Ardelyx, Inc. (NASDAQ: ARDX) Investors Seeking Recovery to Contact the Firm Before November 16, 2026
October 08, 2026
Via NewMediaWire
Topics Lawsuit
News headline image
ARDX SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Ardelyx (NASDAQ: ARDX) Investors of Securities Class Action Lawsuit Deadline on November 16, 2026
October 07, 2026
From Faruqi & Faruqi LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Ardelyx, Inc. of Class Action Lawsuit and Upcoming Deadlines – ARDX
October 06, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
ARDX Investors Have Opportunity to Lead Ardelyx, Inc. Securities Fraud Lawsuit with SBS Law
October 06, 2026
From Schall, Brown & Schwartz LLP
Via GlobeNewswire
News headline image
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Ardelyx, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ARDX
October 05, 2026
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
Important Notice to Long-Term Shareholders of Anavex Life Sciences Corp. (NASDAQ: AVXL); Ardelyx, Inc. (NASDAQ: ARDX); Aardvark Therapeutics, Inc. (NASDAQ: AARD); and GPGI, Inc., f/k/a CompoSecure, Inc. (NYSE: GPGI): Grabar Law Office is Investigating
October 05, 2026
From Grabar Law Office
Via GlobeNewswire
News headline image
Ardelyx to Present New Data on Hyperphosphatemia Management at ASN Kidney Week 2026
October 05, 2026
From Ardelyx, Inc.
Via GlobeNewswire
News headline image
Robbins LLP Urges ARDX Stockholders Who Lost Money Investing in Ardelyx, Inc. to Contact the Firm for Information About Leading the Class Action
October 05, 2026
From Robbins LLP
Via Business Wire
News headline image
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Ardelyx, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ARDX
October 02, 2026
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
ARDX Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Ardelyx, Inc. Securities Lawsuit - Contact Levi & Korsinsky
October 02, 2026
From Levi & Korsinsky, LLP
Via ACCESS Newswire
News headline image
ARDX Investors Have Opportunity to Lead Ardelyx, Inc. Securities Fraud Lawsuit with SBS Law
October 02, 2026
From Schall, Brown & Schwartz LLP
Via GlobeNewswire
News headline image
Kaplan Fox Encourages Ardelyx, Inc. (NASDAQ: ARDX) Investors to Contact the Firm Before the Lead Plaintiff Deadline on November 16, 2026
October 02, 2026
Via NewMediaWire
Topics Lawsuit
News headline image
Robbins LLP is Investigating Allegations that Ardelyx, Inc. Misled Investors Regarding the True State of the Company's Commercial Performance and Growth Prospects for its Two Core Drug Products
September 30, 2026
Via Newsfile
Topics Lawsuit
News headline image
Kaplan Fox Encourages Investors of Ardelyx, Inc. (NASDAQ: ARDX) to Contact the Firm Before Lead Plaintiff Deadline on November 16, 2026
September 30, 2026
Via NewMediaWire
Topics Lawsuit
News headline image
Ardelyx Earns Multiple Honors at the 2026 PM360 Trailblazer Awards
September 30, 2026
From Ardelyx, Inc.
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Ardelyx, Inc. of Class Action Lawsuit and Upcoming Deadlines – ARDX
September 29, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
ARDX Investors Have Opportunity to Lead Ardelyx, Inc. Securities Fraud Lawsuit with SBS Law
September 29, 2026
From Schall, Brown & Schwartz LLP
Via GlobeNewswire
News headline image
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Ardelyx, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ARDX
September 28, 2026
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
Kaplan Fox Reminds Investors of Ardelyx, Inc. (NASDAQ: ARDX) to a Securities Class Action Deadline - Contact the Firm Before November 16, 2026
September 28, 2026
Via NewMediaWire
Topics Lawsuit
News headline image
Kaplan Fox Encourages Investors of Ardelyx, Inc. (NASDAQ: ARDX) to Contact the Firm to Learn About Their Legal Rights
September 25, 2026
Via NewMediaWire
Topics Lawsuit

Frequently Asked Questions

Is Ardelyx, Inc. - Common Stock publicly traded?
Yes, Ardelyx, Inc. - Common Stock is publicly traded.
What exchange does Ardelyx, Inc. - Common Stock trade on?
Ardelyx, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Ardelyx, Inc. - Common Stock?
The ticker symbol for Ardelyx, Inc. - Common Stock is ARDX on the Nasdaq Stock Market
What is the current price of Ardelyx, Inc. - Common Stock?
The current price of Ardelyx, Inc. - Common Stock is 3.230
When was Ardelyx, Inc. - Common Stock last traded?
The last trade of Ardelyx, Inc. - Common Stock was at 10/12/26 04:00 PM ET
What is the market capitalization of Ardelyx, Inc. - Common Stock?
The market capitalization of Ardelyx, Inc. - Common Stock is 333.07M
How many shares of Ardelyx, Inc. - Common Stock are outstanding?
Ardelyx, Inc. - Common Stock has 333M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap